Unknown PHASE1 INTERVENTIONAL NCT00040040

Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1

Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between IV Methamphetamine and Oral Bupropion

Sponsor: National Institute on Drug Abuse (NIDA)

Conditions Amphetamine-Related Disorders

Interventions Bupropion

Updated 5 times since 2017 Last updated: Jan 10, 2017 Started: Jun 30, 2002 Completion: Sep 30, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00040040, this PHASE1 trial focuses on Amphetamine-Related Disorders and remains ongoing. Sponsored by National Institute on Drug Abuse (NIDA), it has been updated 5 times since 2002, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

First recorded

Jun 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
University of California, Los Angeles

Data source: National Institute on Drug Abuse (NIDA)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Houston, United States
• Los Angeles, United States